MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "PTEN induced kinase-1(PINK1)"

  • 2025 International Congress

    Lighting the Torch: Dating the Most Common Recent Ancestor of the PINK1 p.L347P Variant Linked to Parkinson’s Disease in Pacific Populations

    C. Buchanan, A H. Tan, A. Ahmad-Annuar, S-Y. Lim, YW. Tay, T. Siddique, J. Donnelly, G. Monahan, M. Bruno, R. Minster, S. Viali, F. Fa'Alau, C. Puli'Uvea, N. Edwards, G. Vailahi, R. Roxburgh (Auckland, New Zealand)

    Objective: To determine the generational age of the most recent common ancestor (MRCA) of patients homozygous for PINK1 p.L347P, to 1) Test the hypothesis that…
  • 2025 International Congress

    The MJFF PRKN/PINK1 Project

    E-J. Vollstedt, A. Balck, AN. Basak, M. Brand, N. Brüggemann, J-C. Corvol, S. Ertan, M. Funayama, M. Gagliardi, N. Hattori, C-H. Lin, K. Lohmann, P. Mir, D. Narendra, G. Saranza, L. Stefanis, A-H. Tan, EM. Valente, S. Padmanabhan, K. Brockmann, C. Klein (Luebeck, Germany)

    Objective: To i) establish an expert consortium on PRKN/PINK1-linked Parkinson’s disease (PD), ii) improve our understanding of genotype-phenotype relationships and disease mechanisms, and iii) establish…
  • 2025 International Congress

    Distinct roles of PARK2, PINK1, and LRRK2 in neuroinflammation: resistance and susceptibility in immune-mediated mouse models

    D. Cossu, H. Okada, S. Noda, Y. Tomizawa, S. Ueno, L. Sechi, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate the impact of PARK2, PINK1, and LRRK2 deficiency on neuroinflammation in aging, using immune-mediated mouse models. Background: Emerging evidence links mitophagy-related genes, including PARK2 (PARKIN), PINK1, and LRRK2, to immune…
  • 2025 International Congress

    PINK1 activation improves outcomes in the UQCRC1 models of Parkinson’s disease

    JL. Li, CC. Chan, CH. Lin (New Taipei City, Taiwan)

    Objective: To investigate the role of chronic oxidative phosphorylation (OXPHOS) stress in mitophagy and the therapeutic potential of PINK1 activation in the UQCRC1 models of…
  • 2025 International Congress

    Exploring Neuroprotective Role of Natural Compound by Targeting c-Abl Kinase in Parkinson’s Disease

    D. Khatri (Chandwaji, Jaipur, India)

    Objective: To explore c-Abl kinase activation and neuron death pathway in Parkinson’s Disease (PD) mouse model. Assess neuroprotection natural compounds, Rosmarinic acid (RA) with proven…
  • 2025 International Congress

    Familial parkinson disease A comparative study between LRRK2 and PINK 1 mutations

    A. Mousli, R. Zouari, Z. Saeid, F. Nabli, A. Rachdi, D. Ben Mohamed, S. Ben Sassi (Tunis, Tunisia)

    Objective: Describe the clinical phenotypes of monogenic forms of PD linked to LRRK2 and PINK1 mutations with a view to a comparative study between the…
  • 2024 International Congress

    A novel single-cell reporter identifies regulators of the endogenous PINK1-Parkin mitochondrial quality control pathway

    J. Thayer, X. Huang, J. Hawrot, D. Ramos, M. Ward, D. Narendra (BETHESDA, USA)

    Objective: We aimed to identify genome-wide regulators of the PINK1-Parkin pathway using a novel flow cytometry reporter, endogenously tagged MFN2, as a readout of the…
  • 2024 International Congress

    Clinico-genetic profile of five patients with PARK-PINK1: A case series from India

    A. Gunasekaran, P K. Pal, R. Yadav, N. Kamble, V. Holla (Bangalore, India)

    Objective: The aim of our study is to describe the clinical features and genetic profile of patients of PARK-PINK1 and to draw correlation with genetic…
  • 2023 International Congress

    Genetic study of early-onset Parkinson’s disease in the Malaysian population

    YW. Tay, AH. Tan, JL. Lim, K. Lohmann, K. Azmi Ibrahim, Z. Abdul Aziz, YT. Chin, AS. Mawardi, TT. Lim, I. Looi, YK. Chia, JCE. Ooi, WK. Cheah, A. Dy Closas, LC. Lit, JW. Hor, TS. Toh, K. Muthusamy, P. Bauer, V. Skrahin, A. Rolfs, C. Klein, A. Ahmad-Annuar, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: This study aimed to investigate the genetic architecture of EOPD in a multi-ethnic Malaysian cohort. Background: About 5-10% of Parkinson’s disease (PD) cases are…
  • MDS Virtual Congress 2021

    Genotypic and phenotypic spectrum of PINK-1 associated parkinsonism in 44 mutation carriers from 11 Tunisian families

    G. El Fessi, Z. Saied, F. Nebli, M. Zouari, S. Belal, S. Ben Sassi (Tunis, Tunisia)

    Objective: To characterize the family history and clinical features of mutations of the PINK-1 gene in a cohort of Tunisian patients with Parkinson disease (P.D)…
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley